S1PR1 and hepatocellular carcinoma: Recent studies have suggested that the metabolites from this pathway, such as ceramide, sphingosine 1-phosphate, and sphingosine 1-phosphate receptor, may have therapeutic potential for liver regeneration, fibrosis, and hepatocellular carcinoma (HCC).